Ripple's payment system now includes a recovery process for cross-border transfers that fail after XRP withdrawal but before deposit confirmation. This process allows the system to retry payments multiple times over several hours and can convert XRP into fiat, placing funds into a Sender Segregated Account (SSA) for reuse in future payments. The SSA acts as a nostro account holding fiat owed to the sender, enabling liquidity preservation even if the original transaction is marked as failed. This feature enhances the efficiency and reliability of Ripple's cross-border payment network by reducing lost funds and supporting multiple foreign-exchange configurations.
Ripple's new recovery process for failed XRP cross-border payments is highlighted alongside Pluang's cryptocurrency market data. For readers following digital assets, here is Pluang's market snapshot as of Oct 07, 2026 19:23 WIB: out of 50 major cryptocurrencies, 5 rose and 44 fell today. Notable movers include BAL (Balancer) at Rp16.297 with an 11.14% gain, ENJ (Enjin Coin) at Rp528 down 11.01%, and EGLD (MultiversX) at Rp72.449 down 10.74%.
DA Davidson raised its price target for Micron Technology stock from $2,100 to $3,000, implying a 194.9% potential gain from the current price around $1,017. The firm argues that AI has transformed memory chips into a durable growth business, justify...
Marvell Technology's stock surged 231% year-to-date but still has about 42% upside to Wall Street's raised price targets following its October 2026 Investor Day. Several firms, including BofA, Needham, and Piper Sandler, raised their price targets to...
Nearly all analysts covering Microsoft are bullish, with a consensus price target of $630, implying a 21.7% upside from the current price of $517.53. Strong growth in Azure cloud services and AI products like Microsoft 365 Copilot drive optimism, sup...
Johnson & Johnson has achieved its 64th consecutive year of dividend increases, raising its quarterly dividend by 3.1% to $1.34 per share in 2026. Despite strong overall sales growth driven by new drugs like Tremfya and Darzalex, the company faces si...
Wells Fargo analyst Ken Gawrelski raised his price target for Meta to $1,000, the highest among analysts, implying 35% upside. However, he expects Meta's earnings in 2027 to be below consensus due to high expenses and slow initial revenue from its ne...
